PRL and breast carcinoma: In this population-based case-control study we evaluated the effects of SSRI use on breast cancer risk as a function of their relative degree of inhibition of serotonin reuptake, a proxy for their impact on prolactin levels, and their duration of use, as well as the potentially risk-modifying effects of menopausal status.